Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bezafibrate on muscle metabolism during exercise in patients with fat metabolic disorders in skeletal muscle
2008-006704-27Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bezafibrate in very long-chain acyl-CoA dehydrogenase deficiency, carnitine palmitoyltransferase 2 deficiency (CPT2) and muscle diseases (NMD), sponsored by Rigshospitalet. Primary endpoint: Primary muscle metabolism outcomes. Started Jun 2009; status: completed.
02
Drugs
bezafibrate
03
Conditions
very long-chain acyl-CoA dehydrogenase deficiencycarnitine palmitoyltransferase 2 deficiency (CPT2)muscle diseases (NMD)
Beyond the preview
Go deeper on 2008-006704-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006704-27.